Trial · NCT04264156
Adverse events106
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 106
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia neonatal | Blood and lymphatic system disorders | Lucinactant (160 mg/kg) + nCPAP | 8 | 11 | 9 |
| other | Anemia neonatal | Blood and lymphatic system disorders | nCPAP Only | 0 | 1 | 0 |
| other | Coagulation disorder neonatal | Blood and lymphatic system disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Coagulation disorder neonatal | Blood and lymphatic system disorders | nCPAP Only | 0 | 1 | 0 |
| other | Leukocytosis | Blood and lymphatic system disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Leukocytosis | Blood and lymphatic system disorders | nCPAP Only | 0 | 1 | 0 |
| other | Neutropenia | Blood and lymphatic system disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Neutropenia | Blood and lymphatic system disorders | nCPAP Only | 0 | 1 | 0 |
| other | Tachycardia | Cardiac disorders | Lucinactant (160 mg/kg) + nCPAP | 2 | 11 | 2 |
| other | Tachycardia | Cardiac disorders | nCPAP Only | 0 | 1 | 0 |
| other | Congenital pneumonia | Congenital, familial and genetic disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Congenital pneumonia | Congenital, familial and genetic disorders | nCPAP Only | 0 | 1 | 0 |
| other | Duodenal atresia | Congenital, familial and genetic disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Duodenal atresia | Congenital, familial and genetic disorders | nCPAP Only | 0 | 1 | 0 |
| other | Patent ductus arteriosus | Congenital, familial and genetic disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Patent ductus arteriosus | Congenital, familial and genetic disorders | nCPAP Only | 0 | 1 | 0 |
| other | Abdominal distension | Gastrointestinal disorders | Lucinactant (160 mg/kg) + nCPAP | 3 | 11 | 3 |
| other | Abdominal distension | Gastrointestinal disorders | nCPAP Only | 0 | 1 | 0 |
| other | Haematochezia | Gastrointestinal disorders | Lucinactant (160 mg/kg) + nCPAP | 1 | 11 | 1 |
| other | Haematochezia | Gastrointestinal disorders | nCPAP Only | 0 | 1 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04264156/events